LiSyM: The better way to manage your data
Free and open platform for easier research data management
Latest additions
- A liver digital twin for in silico testing of cellular and inter-cellular mechanisms in regeneration after drug-induced damage.
Publication - added 4 days ago - Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.
Publication - added 4 days ago - Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure.
Publication - added 4 days ago - Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes.
Publication - added 4 days ago - The TGF-beta1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.
Publication - added 4 days ago - Digitoxin metabolism by rat liver microsomes.
Publication - added 4 days ago - Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes
Publication - added 4 days ago - SOP template based on nature protocol format and reqiremeents
SOP - added about 1 month ago - Supplementary Tables 1-7: Multiomics and kinetic modeling reveal dominance of 12-hour rhythms in global liver metabolism
Data file - added about 2 months ago - Proteomics_raw_data_Hh_modulation_murine_hepatocytes
Data file - added about 2 months ago
Find content
LiSyM (Liver Systems Medicine) represents a research network of German centers and institutions, brought together by a 20 Million Euro funding program of the German Government, in which mathematicians, modelers, pharmacologists, molecular biologists and clinical scientists work together to develop a Systems Medicine approach to study early and advanced liver disease.
The aim of this unique research program is to acquire and use new experimental data and data from existing data bases to build computational models that facilitate decision making at the patient's bedsite and to predict the actions of new medicines in the treatment of metabolic liver disease.